F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to ensure medications were administered safely
for 2 of 5 residents (R2 and R3) reviewed for medication administration in sample of 7.
The findings include:
R2's admission Record documents an admission date of 7/27/2017 and includes diagnoses of Chronic
Obstructive Pulmonary Disease (COPD), Atrial Fibrillation, Reduced Mobility, Anxiety, and Major
Depressive Disorder. R2's Minimum Data Set (MDS) dated [DATE] documents in Section C, Cognitive
Patterns, a Brief Interview for Mental Status (BIMS) score of 15, indicating R2 is cognitively intact. The
same MDS documents in section E, Behaviors, is coded 0 for behaviors. R2's Order Summary Report
dated 8/28/2024 does not include orders for Nystatin Powder. R2's Care Plan with a revision date of 7/27/24
does not include focus area or interventions addressing behaviors or R2's ability for self-administration of
medications.
On 8/28/2024 at 11:10 AM, R2 was observed sitting in her room. A bottle labeled Nystatin Powder was
observed sitting on the bedside table next to R2. The bottle was ½ full and contained powder. The
pharmacy label on the bottle documented R2's name and instructions to apply Nystatin powder 4 times a
day for 10 days with order date of 4/3/2024. R2 was alert and oriented to person, place, and time. R2 stated
she applied the medication (Nystatin Powder) herself and she still applies the powder under her breast at
times. R2 stated she normally keeps it in her bin, but she has been using it, so she sat it on her bedside
table.
R3's Face admission Record documents an admission date of 8/19/2023 with diagnoses including Major
Depression Disorder, Anxiety, Ulcerative Colitis, and Parkinson's Disease with Dyskinesia. R3's MDS dated
[DATE] includes a BIMS score of 9, indicating R3 has moderate cognitive impairment. R3's Order Summary
Report Physician dated 8/28/2024 documents current orders for Sulfasalazine 500 mg (milligrams) oral
tablet, give 2 tablets by mouth three times a day related to ulcerative colitis, and Carbidopa-Levodopa tablet
25-250mg, give 1 tablet by mouth three times a day for Parkinson's disease related to Tremors.
On 8/28/2024 at 11:35 AM, R3 was observed in her room lying in bed asleep. A medication cup containing
1 blue pill and 2 orange pills were observed sitting on bedside table in R3's room. At this time, V6
(Registered Nurse) walked by R3's room. V6 was asked about the medication cup that contained the 3 pills
and V6 stated this is not my hall so I didn't leave the pills there, those shouldn't be there. V6 identified the
resident lying in the bed as R3 and stated that she is confused.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
145890
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145890
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/30/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Eldorado Rehab & Healthcare
1001 A Jefferson Street
Eldorado, IL 62930
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
On 8/28/2024 at 11:40AM, V2 (Director of Nursing) entered R3's room. R3 was then sitting up on the side
of the bed. R3 noted to be confused. R3 was asked if those were her medications sitting on the bedside
table and R3 stated I guess they are. V2 stated well (R3) is very slow at taking her medications, it takes a
long time, and she won't take her medications until she is ready to take them. V2 was asked if it is their
policy to leave medications at bedside and V2 replied no, it isn't. V2 was asked who the medication nurse
that was working the hall and she stated V8 (Registered Nurse). V2 then took the medications and left the
room. V2 was asked if R3 could make her own decisions, V2 stated No. V2 then took the medications and
left the room.
On 8/28/2024 at 12:30 PM, V8 (Registered Nurse) was asked if she was the medication nurse for R3 and
V8 stated yes, I am. V8 was asked is R3 was confused, V8 stated yes, she is confused most of the time. V8
was asked if she left medications sitting on the bedside table in R3's room, V8 stated (R3) has this funny
thing about wanting to keep them in her room, sometimes she refuses to take them until she eats her
cereal, so you just have to go along with her because she is confused, I do it all the time. V8 was asked if
she leaves medications in R3's room frequently and she stated, yes because she wants us to. V8 was
asked if she knows what the facility policy is on medication administration, V8 stated Our policy says we
should not do that. We should probably stand there until she takes them. V8 was asked to pull R3's
medication cards from the medication cart to identify what medications were in the medicine cup on R3's
bedside table. V8 pulled R3's medication cards and identified that the medications were the 12 PM doses
Sulfasalazine 500 mg 2 tablets and Carbidopa-Levodopa 25/250 mg one tablet per the pharmacy label on
the medication cards. V8 stated yes, these are the medications that were left in R3's room.
On 8/28/2024 at 1:15PM, V2 DON (Director of Nursing) stated her expectation is that medications are not
left at the bedside unless ordered by the physician. V2 was asked if R2 and R3 had assessments done to
be able to self-administer medications, V2 stated I am not sure and I don't know if those type of
assessments are in PCC (Point Click Care). V2 stated she recently did education to the nurses on narcotic
counts and medications. V2 stated, she can't say she has never seen medications left at bedside, but she
hasn't seen any medications at the bedside lately, at lease the last several months except creams and
powders. V2 was asked about R2's Nystatin Powder left at bedside. V2 stated (R2) has behaviors and will
not let us take the powder. V2 stated R2 is alert and oriented and knows everything going on and she will
not let us remove the medicated powder from her room. V2 was asked if she felt Nystatin powder was a
prescribed medication, V2 stated yes, it is. V2 was asked if she realized the order was dated for 4/3/2024
and was for 10 days, she stated she would have to check. V2 wasn't sure if the physician was aware R2
was still using the medication. V2 was asked if R2 had an assessment for self-administration of medications
and she stated she didn't know because she doesn't know if (name of electronic health record system) has
those assessments. Documentation of an assessment to determine R2's ability to self-administer
medications were requested at this time for review and none were provided during the survey.
The facility policy titled Medication Administration (revision date December 2012) documents a Policy
Statement of Medications shall be administered in a safe and timely manner, and as prescribed. The Policy
Interpretation and Implementation step #24 documents Residents may self-administer their own
medications only if the Attending Physician, in conjunction with the Interdisciplinary Care Planning Team,
has determined that they have the decision-making capacity to do so safely. results were observed and the
person administering the drug.
The facility policy titled Self-Administration of Medications (revision date December 2016) documents a
Policy Statement of Residents have the right to self-administer medications if the
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145890
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145890
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/30/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Eldorado Rehab & Healthcare
1001 A Jefferson Street
Eldorado, IL 62930
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
interdisciplinary team has determined that it is clinically appropriate and safe for the resident to do so. The
Policy Interpretation and Implementation documents the following: 1. As part of their overall evaluation, the
staff and practitioner will assess each resident's mental and physical abilities to determine whether
self-administering medications is clinically appropriate for the resident. 2. In addition to general evaluation
of decision-making capacity, the staff and practitioner will perform a more specific skill assessment,
including (but not limited to) the resident's: a. Ability to read and understand medication labels; b.
Comprehension of the purpose and proper dosage and administration time for his or her medications; c.
Ability to remove medications from a container and to ingest and swallow (or otherwise administer) the
medication; and d. Ability to recognize risks and major adverse consequences of his or her medications. 3.
If the team determines that a resident cannot safely self-administer medications, the nursing staff will
administer the resident's medications . 8. Self-administered medications must be stored in a safe and
secure place, which is not accessible by other residents. If safe storage is not possible in the resident's
room, the medications of residents permitted to self-administer will be stored on a central medication cart
or in the medication room. Nursing will transfer the unopened medication to the resident when the resident
requests them. 9. Staff shall identify and give to the Charge Nurse any medications found at the bedside
that are not authorized for self-administration, for return to the family or responsible party.
Event ID:
Facility ID:
145890
If continuation sheet
Page 3 of 3